傳美敦力將以44億美元收購LivaNova 加強神經調節事業 | 合法醫療器材資訊網

Our VNS Therapy® System for drug-resistant epilepsy has treated more than 125,000 patients around the world. VNS Therapy can lead to fewer seizures, shorter ... Read More

VNS Therapy Patient MRI safety information ... VNS Therapy Healthcare Professionals MRI safety information ... VNS Therapy for Epilepsy Manual Library​. Read More

2020年3月9日 — The VNS Therapy System, Symmetry™, is indicated in the U.S. for the adjunctive long-term treatment of chronic or recurrent depression for ... Read More

2019年7月11日 — VNS Therapy is designed to prevent seizures before they occur and stop them if they do. It is a unique treatment approach developed for people ... Read More

2020年7月7日 — 7, 2020-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical ... “VNS Therapy for treatment-resistant depression has proven to be a safe ... Read More

2019年12月5日 — VNS Therapy is designed to prevent seizures before they occur and stop them if they do. It is a unique treatment approach developed for people ... Read More

2020年1月2日 — The VNS Therapy SenTiva Generator System is used for Vagus Nerve Stimulation (VNS) therapy to reduce the frequency of seizures in adults ... Read More

As a healthcare company committed to improving the lives of patients around the world, LivaNova is closely monitoring the coronavirus (COVID-19) situation and ... Read More

相反，LivaNova是VNS的市場領導者，其神經調節市場占有率為9%。 不過，如果LivaNova的心節律管理（Cardiac Rhythm Management）、心臟手術（Cardiac ... Read More